Insider track record
OtherNot enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the complete record of transactions filed by Holm-Jorgensen Rasmus. Officer active across 1 company, notably Acrivon Therapeutics, Inc.. In total, 8 disclosures have been recorded. Activity tracked since 14 November 2022. The latest transaction was filed on 14 February 2025 (Retenue fiscale). Regulator: SEC (Form 4). The full history is free.
Declarations8 total
434 shares@ US$5.424.5% of flowCommon StockSEC:0000905148-25-000728:0
368 shares@ US$7.925.5% of flowCommon StockSEC:0000905148-24-003226:0
368 shares@ US$7.024.7% of flowCommon StockSEC:0000905148-24-002280:0
368 shares@ US$8.365.7% of flowCommon StockSEC:0000905148-24-001489:0
434 shares@ US$3.402.8% of flowCommon StockSEC:0000905148-24-000763:0
1,470 shares@ US$5.0813.9% of flowCommon StockSEC:0000905148-23-001475:0
9,500 shares@ US$3.6362.9% of flowCommon StockSEC:0001140361-23-030544:0
20,030 shares0Common StockSEC:0001209191-22-057398:0